The ongoing COVID-19 pandemic has now thrown us into turmoil by adversely affecting the entire socio-economic structure of the world. Currently (Dec20, 2020), there are 76.4 million incidences worldwide and 17.6 million in the USA, and counting. Primarily in this scenario, all the resources available at hospitals and medical care units are reasonably redirected to address the contagious COVID-19 infected patients. This is an issue for a cancer patient, who may be at risk or infected with Coronavirus needs to be managed amid multiple unknown complications. Many issues are still unanswered and an attempt to streamline various strategies is being offered by Oncologists around the world to treat cancer patients. The gravest concerns are related to deciding suitable supervision for a positive COVID-19 cancer patient undergoing a cycle of chemo/radiotherapy; handling advanced stage of cancer in regions profoundly affected by virus; evaluating the risk-benefit parameters for treatment or surgeries; planning routine screening and precaution for weak patients, medical staff and others in the community. Here we have presented the different guidelines, schemes, and strategies accessible from several Oncology departments and organizations in multiple countries.